The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross‐talk, and therapies

Publisher： John Wiley & Sons Inc

E-ISSN： 1601-0825|1354-523X|7|815-825

ISSN： 1354-523x

Source： ORAL DISEASES, Vol.1354-523X, Iss.7, 2015-10, pp. : 815-825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross‐talk, and therapies

By  

ORAL DISEASES, Vol. 21, Iss. 7, 2015-10 ,pp. : 815-825

John Wiley & Sons Inc

Access to resources Recommend Favorite

GOLM1 promotes prostate cancer progression through activating PI3K‐AKT‐mTOR signaling

By  

THE PROSTATE, Vol. 78, Iss. 3, 2018-02 ,pp. : 166-177

John Wiley & Sons Inc

Access to resources Recommend Favorite

PI3K/PTEN/AKT/mTOR polymorphisms: Association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab‐docetaxel

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 4, 2015-04 ,pp. : 471-478

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway

By            

International Journal of Molecular Medicine, Vol. 35, Iss. 5, 2015-01 ,pp. : 1301-1308

Spandidos Publications

Access to resources Recommend Favorite

Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells

By          

International Journal of Molecular Medicine, Vol. 36, Iss. 6, 2015-01 ,pp. : 1556-1562

Spandidos Publications

Access to resources Recommend Favorite